Stay updated on FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Sign up to get notified when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.

Latest updates to the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page
- Check3 days agoChange DetectedThe page updates the revision from v3.0.1 to v3.0.2 and removes the Back to Top element. This does not affect core content or other critical information.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of multiple facility locations across various countries, such as Belgium, Brazil, Italy, Japan, Poland, Russia, Spain, Turkey, and Ukraine. Additionally, a new reference to a pharmacokinetic study has been included, while previous location entries have been removed.SummaryDifference3%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.4%
Stay in the know with updates to FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.